Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method
about
Clinical significance of hepatitis C virus genotypesCurrent molecular methods for the detection of hepatitis C virus in high risk group population: A systematic reviewClinical relevance of hepatitis C virus genotypes.Algorithmic approach to high-throughput molecular screening for alpha interferon-resistant genotypes in hepatitis C patientsComparative Evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR Version 2.0 Assays for Quantification of Hepatitis C Virus RNA in SerumIn Vitro Detection of Dissimilar Amounts of Hepatitis C Virus (HCV) Subtype-Specific RNA Genomes in Mixes Prepared from Sera of Persons Infected with a Single HCV GenotypeFrequent Recovery and Broad Genotype 2 Diversity Characterize Hepatitis C Virus Infection in Ghana, West AfricaClinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infectionMolecular methods of measurement of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection: implications for occupational health practiceMother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus InfectionGenotype dependence of hepatitis C virus load measurement in commercially available quantitative assays.Clinical evaluation of the automated COBAS AMPLICOR HCV MONITOR test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test.Molecular techniques for clinical diagnostic virologyLinkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses.Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection.Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA.Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen.Hepatitis C virus quantitation: optimization of strategies for detecting low-level viremia.Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination.Assessment of viral loads in patients with chronic hepatitis C with AMPLICOR HCV MONITOR version 1.0, COBAS HCV MONITOR version 2.0, and QUANTIPLEX HCV RNA version 2.0 assays.A genotype-independent real-time PCR assay for quantification of hepatitis B virus DNA.Quantitation of the latent HIV-1 reservoir from the sequence diversity in viral outgrowth assays.
P2860
Q24514512-86971ABF-4A75-408D-93F1-BEB74FF4BDFFQ26851978-2B7E0FCE-A750-4DD1-A51A-D0E15F2168CCQ27469323-C541DE6F-E833-4ABB-BE3B-B9DBD4B64389Q27469401-D9504686-CE74-4861-AAC3-9E2A6B819D8BQ27473432-402DF7CE-84DE-4171-AFDC-218390BDCBC2Q27477474-DC48CA4E-2BCC-4B8F-BD0C-84F0231E596CQ27477557-AC3FE1C1-4716-4C5C-8B01-D6AB1E44967AQ27477830-05F9647B-8464-4604-AE07-29BD01EDFC01Q27477932-DC8BF518-799A-4825-A8A0-C73597CEA1D5Q33826256-E7544536-8F95-4F5A-9298-C9C883EE681BQ33961960-BE8529F2-62A0-47F2-8057-59BFC3FAF1F8Q33968828-7D0EFFE1-3EFD-4440-97EB-BDC2353C5143Q34015058-D7A787BC-551D-466F-9C42-44F607DDB5CFQ35354820-8063B583-294B-4B47-8C06-A622D787925FQ36375990-4828521A-BA8B-4B00-B841-46B257CE8FB8Q37241966-E6CE9272-1005-457F-A7C1-7A3CA4C74CB0Q39449520-7EF95BDC-85AF-4B59-BBCE-3B3AA1C9637EQ39455553-6753C796-CDE5-41EF-8C90-2583590DB405Q39458171-474639E5-4F50-45D1-8F3E-BA35519947C2Q39459300-F1CB5FE7-18AE-4D89-B46B-96292133EF65Q42912545-5447B833-05C9-4512-916F-1FC6F467670DQ55498078-3F280675-BCD7-4000-89C3-F1BA6956646A
P2860
Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Comparison of plasma virus loa ...... house limiting dilution method
@ast
Comparison of plasma virus loa ...... house limiting dilution method
@en
Comparison of plasma virus loa ...... house limiting dilution method
@nl
type
label
Comparison of plasma virus loa ...... house limiting dilution method
@ast
Comparison of plasma virus loa ...... house limiting dilution method
@en
Comparison of plasma virus loa ...... house limiting dilution method
@nl
prefLabel
Comparison of plasma virus loa ...... house limiting dilution method
@ast
Comparison of plasma virus loa ...... house limiting dilution method
@en
Comparison of plasma virus loa ...... house limiting dilution method
@nl
P2093
P2860
P1476
Comparison of plasma virus loa ...... house limiting dilution method
@en
P2093
P2860
P304
P407
P577
1997-01-01T00:00:00Z